David M. Maahs

31.3k total citations · 9 hit papers
369 papers, 17.5k citations indexed

About

David M. Maahs is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, David M. Maahs has authored 369 papers receiving a total of 17.5k indexed citations (citations by other indexed papers that have themselves been cited), including 281 papers in Endocrinology, Diabetes and Metabolism, 157 papers in Genetics and 148 papers in Surgery. Recurrent topics in David M. Maahs's work include Diabetes Management and Research (250 papers), Diabetes and associated disorders (154 papers) and Pancreatic function and diabetes (136 papers). David M. Maahs is often cited by papers focused on Diabetes Management and Research (250 papers), Diabetes and associated disorders (154 papers) and Pancreatic function and diabetes (136 papers). David M. Maahs collaborates with scholars based in United States, Canada and Australia. David M. Maahs's co-authors include Roy W. Beck, Janet K. Snell‐Bergeon, Linda A. DiMeglio, Nicole C. Foster, Kellee M. Miller, Marian Rewers, William V. Tamborlane, Elizabeth J. Mayer‐Davis, Richard M. Bergenstal and Jean M. Lawrence and has published in prestigious journals such as Circulation, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

David M. Maahs

351 papers receiving 17.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018

2019 1.4k citations Nicole C. Foster, Kellee M. Miller et al. Diabetes Technology & Therapeutics profile →
Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

2015 983 citations Kellee M. Miller, Nicole C. Foster et al. Diabetes Care profile →
Epidemiology of Type 1 Diabetes

2010 792 citations David M. Maahs, Nancy A. West et al. profile →
ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes

2018 434 citations Carlo L. Acerini, Ethel Codner et al. Pediatric Diabetes profile →
Update: Ambulatory Blood Pressure Monitoring in Children and Adolescents

2014 371 citations Joseph T. Flynn, Stephen R. Daniels et al. Hypertension profile →
Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association

2018 311 citations David M. Maahs, Korey K. Hood et al. Diabetes Care profile →
ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes

2022 121 citations Ethel Codner, Maria E. Craig et al. Pediatric Diabetes profile →
Longitudinal Trends in Glycemic Outcomes and Technology Use for Over 48,000 People with Type 1 Diabetes (2016–2022) from the T1D Exchange Quality Improvement Collaborative

2023 76 citations Osagie Ebekozien, Janine Sanchez et al. Diabetes Technology & Therapeutics profile →
Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: Results from the International diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0

2025 25 citations Graham D. Ogle, Aveni Haynes et al. Diabetes Research and Clinical Practice profile →

Peers

Countries citing papers authored by David M. Maahs

Since Specialization

Citations

This map shows the geographic impact of David M. Maahs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Maahs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Maahs more than expected).

Fields of papers citing papers by David M. Maahs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Maahs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Maahs. The network helps show where David M. Maahs may publish in the future.

Co-authorship network of co-authors of David M. Maahs

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Maahs. A scholar is included among the top collaborators of David M. Maahs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Maahs. David M. Maahs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: Results from the International diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0 breakdown → 2025 ·Diabetes Research and Clinical Practice ·Graham D. Ogle, (unknown), Aveni Haynes, Gabriel A Gregory, (unknown), (unknown), Dana Dabelea, Steven James, Alicia J. Jenkins, Xia Li, Ronald C.W., David M. Maahs, Richard A. Oram, Catherine Pihoker, Jannet Svensson, Zhiguang Zhou, Dianna J. Magliano, Jayanthi Maniam	25
2	1456-P: Type 1 Diabetes Care and Device Use in Older Adults—Transatlantic Comparison Based on T1DX-QI and DPV Registries 2024 ·Diabetes ·(unknown), Stefanie Lanzinger, Saketh Rompicherla, (unknown), Grenye O’Malley, (unknown), (unknown), Florian Kopp, David M. Maahs, (unknown), Osagie Ebekozien, (unknown), (unknown)	1
3	Longitudinal Trends in Glycemic Outcomes and Technology Use for Over 48,000 People with Type 1 Diabetes (2016–2022) from the T1D Exchange Quality Improvement Collaborative breakdown → 2023 ·Diabetes Technology & Therapeutics ·Osagie Ebekozien, (unknown), Janine Sanchez, Saketh Rompicherla, (unknown), Ruth S. Weinstock, Laura M. Jacobsen, Georgia M. Davis, Alexis M. McKee, Halis Kaan Aktürk, David M. Maahs, Manmohan K. Kamboj, (unknown)	76
4	Using Peer Power to Reduce Health Disparities: Implementation of a Diabetes Support Coach Program in Federally Qualified Health Centers 2022 ·Diabetes Spectrum ·Ashby F. Walker, Ananta Addala, (unknown), Rayhan Lal, Michael J. Haller, (unknown), Stephanie L. Filipp, L. Baer, Matthew J. Gurka, Angelina Bernier, (unknown), Sarah Westen, Korey K. Hood, (unknown), Eliana Frank, (unknown), (unknown), David M. Maahs	14
5	Temporal Changes in Hemoglobin A1c and Diabetes Technology Use in DPV, NPDA, and T1DX Pediatric Cohorts from 2010 to 2018 2022 ·Diabetes Technology & Therapeutics ·Rayhan Lal, (unknown), Stefanie Lanzinger, Kellee M. Miller, (unknown), (unknown), Peter Calhoun, Fiona Campbell, (unknown), David M. Maahs, Reinhard W. Holl, Justin Warner	9
6	Algorithm-Enabled, Personalized Glucose Management for Type 1 Diabetes at the Population Scale: Prospective Evaluation in Clinical Practice 2022 ·JMIR Diabetes ·David Scheinker, (unknown), (unknown), Andrew Ward, (unknown), (unknown), (unknown), Korey K. Hood, Ming Yeh Lee, David M. Maahs, Priya Prahalad	14
7	Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System Among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation Study 2021 ·Diabetes Technology & Therapeutics ·Gregory P. Forlenza, Tim Vigers, Cari Berget, Laurel H. Messer, Rayhan Lal, Marina Basina, David M. Maahs, Korey K. Hood, Bruce A. Buckingham, Darrell M. Wilson, R. Paul Wadwa, Kimberly A. Driscoll, Laura Pyle	9
8	Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study 2021 ·The Journal of Clinical Endocrinology & Metabolism ·Carla Demeterco‐Berggren, Osagie Ebekozien, Saketh Rompicherla, Laura M. Jacobsen, Siham Accacha, Mary Gallagher, G. Todd Alonso, Berhane Seyoum, Francesco Vendrame, J. Sonya Haw, Marina Basina, Carol J. Levy, David M. Maahs	22
9	Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance 2020 ·Pediatric Diabetes ·Ananta Addala, David M. Maahs, David Scheinker, (unknown), (unknown), Priya Prahalad	54
10	Five heterogeneous HbA1c trajectories from childhood to adulthood in youth with type 1 diabetes from three different continents: A group‐based modeling approach 2019 ·Pediatric Diabetes ·Mark A. Clements, Anke Schwandt, Kim C. Donaghue, Kellee M. Miller, (unknown), Jennifer Couper, Nicole C. Foster, Carmen Schröder, Helen Phelan, David M. Maahs, Nicole Prinz, Maria E. Craig	34
11	Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c 2019 ·Pediatric Diabetes ·Anna R. Kahkoska, (unknown), Allison E. Aiello, Kyle S. Burger, John B. Buse, Jamie Crandell, David M. Maahs, (unknown), Michael R. Kosorok, Elizabeth J. Mayer‐Davis	10
12	One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System 2019 ·Diabetes Care ·Rayhan Lal, Marina Basina, David M. Maahs, Korey K. Hood, Bruce A. Buckingham, Darrell M. Wilson	159
13	Genetic Determinants of Glycated Hemoglobin in Type 1 Diabetes 2019 ·Diabetes ·Anna Syreeni, Niina Sandholm, Jingjing Cao, Iiro Toppila, David M. Maahs, Marian Rewers, Janet K. Snell‐Bergeon, Tina Costacou, Trevor J. Orchard, M. L. Caramori, Michael Mauer, Barbara E.K. Klein, Ronald Klein, Erkka Valo, Maija Parkkonen, Carol Forsblom, Valma Harjutsalo, Andrew D. Paterson, Per‐Henrik Groop	14
14	ISPAD Clinical Practice Consensus Guidelines 2018: Introduction to the Limited Care guidance appendix 2018 ·Pediatric Diabetes ·Ethel Codner, Carlo L. Acerini, Maria E. Craig, Sabine E. Hofer, David M. Maahs	4
15	Dysglycemia among youth with type 1 diabetes and suboptimal glycemic control in The Flexible Lifestyle Empowering Change (FLEX) trial 2018 ·Pediatric Diabetes ·Anna R. Kahkoska, Jamie Crandell, Kimberly A. Driscoll, Jessica Kichler, Michael Seid, Elizabeth J. Mayer‐Davis, David M. Maahs	4
16	Prevalence of Celiac Disease in 52,721 Youth With Type 1 Diabetes: International Comparison Across Three Continents 2017 ·Diabetes Care ·Maria E. Craig, (unknown), Claire T. Boyle, Fiona Campbell, Timothy W. Jones, Sabine Hofer, Jill H. Simmons, Naomi Holman, Elaine Tham, Elke Fröhlich‐Reiterer, Stephanie N. DuBose, Helen Thornton, Bruce R. King, David M. Maahs, Reinhard W. Holl, Justin Warner, (unknown), (unknown)	92
17	Update: Ambulatory Blood Pressure Monitoring in Children and Adolescents breakdown → 2014 ·Hypertension ·Joseph T. Flynn, Stephen R. Daniels, Laura L. Hayman, David M. Maahs, Brian W. McCrindle, Mark Mitsnefes, Justin P. Zachariah, Elaine M. Urbina	371
18	Assessment and monitoring of glycemic control in children and adolescents with diabetes 2014 ·Pediatric Diabetes ·Marian Rewers, Kubendran Pillay, Carine de Beaufort, Maria E. Craig, Ragnar Hanås, Carlo L. Acerini, David M. Maahs	240
19	Introduction to the limited care guidance appendix 2014 ·Pediatric Diabetes ·Carlo L. Acerini, Maria E. Craig, Carine de Beaufort, David M. Maahs, Kubendran Pillay, Ragnar Hanås	2
20	Association of insulin sensitivity to lipids across the lifespan in people with Type 1 diabetes 2010 ·Diabetic Medicine ·David M. Maahs, Kristen J. Nadeau, Janet K. Snell‐Bergeon, Irene E. Schauer, Bryan C. Bergman, Nancy A. West, Marian Rewers, Stephen R. Daniels, Lorraine G. Ogden, Richard F. Hamman, Dana Dabelea	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact